Federated Hermes, Inc. Summit Therapeutics Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$2.39 - $10.92 $16,471 - $75,260	-6,892 Reduced 1.25%	544,877 $4.25 Million
Q1 2024 May 14, 2024	BUY	$2.55 - $5.07 $1.38 Million - $2.74 Million	539,453 Added 4380.1%	551,769 $2.28 Million
Q4 2023 Jan 31, 2024	SELL	$1.67 - $2.83 $9,286 - $15,737	-5,561 Reduced 31.11%	12,316 $32,000
Q3 2023 Nov 13, 2023	BUY	$1.54 - $2.42 $27,530 - $43,262	17,877 New	17,877 $33,000

192

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.6B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.